Most peptide degradation in a laboratory is not caused by bad material. It’s caused by handling, and the specific errors are consistent enough to list.
This is a reference to the ways samples get compromised, roughly in order of how often they occur, with the mechanism for each — because knowing why something causes damage makes it easier to recognise the situations where it applies.
1. Opening a cold vial
The error: taking a vial from −20 °C and breaking the seal immediately.
The mechanism: lyophilised peptide is highly porous and hygroscopic. A cold surface exposed to room air condenses atmospheric moisture directly onto the powder. That water then drives hydrolysis and deamidation in material that was specifically dried to prevent them.
The fix: let the sealed vial reach room temperature first — twenty to thirty minutes for a standard vial. Every time it’s opened, not just the first.
This is the most common single error in peptide handling, and the easiest to avoid.
2. Freeze–thaw cycling of solutions
The error: freezing and thawing a reconstituted stock repeatedly.
The mechanism: ice crystal formation mechanically disrupts peptide structure, and the growing ice front concentrates solutes in the shrinking unfrozen fraction — driving local concentration high enough to promote aggregation. Damage is cumulative and largely irreversible.
The fix: aliquot into single-use volumes immediately after reconstitution, before the first freeze. Thaw one, use it, discard the remainder.
Worth being precise: this applies to solutions only. Dry lyophilised powder has no meaningful free water, so temperature cycling doesn’t produce this damage. People frequently apply the concern backwards.
3. Vigorous mixing
The error: vortexing at speed, or shaking to dissolve.
The mechanism: two things at once. Shear forces disrupt structure directly, and air entrainment creates an air–liquid interface where peptides preferentially adsorb and denature. Foam traps material at the surface, so recovery drops as well.
The fix: add solvent down the vial wall rather than onto the cake, then swirl gently or let it stand. Most peptides dissolve within minutes. If one resists, the answer is usually a different solvent, not more agitation.
4. Oxidation of susceptible residues
The error: leaving oxidation-prone sequences exposed to air, particularly in solution.
The mechanism: methionine oxidises to the sulfoxide (mass +16 Da), cysteine forms disulfides, and tryptophan degrades through several pathways. Dissolved oxygen, trace metal contamination, and light all accelerate it.
The fix: minimise headspace air, reduce the number of times a vial is opened, store dark, and consider an inert gas overlay for particularly sensitive material. Where a sequence contains multiple susceptible residues, treat solution stability as shorter than the general guidance.
Susceptible residues: Met, Cys, Trp, and to a lesser extent Tyr and His.
5. Adsorption to container surfaces
The error: storing dilute solutions in ordinary plastic or glass, and assuming concentration is what you calculated.
The mechanism: peptides adsorb to surfaces, and the effect is proportionally larger at low concentration and high surface-area-to-volume ratio. A dilute solution in a large tube can lose a meaningful fraction of its peptide to the walls. Hydrophobic and highly charged sequences are worst affected.
The fix: use low-binding tubes for dilute work, minimise transfers between containers, add carrier protein where the assay permits, and prepare dilute working solutions fresh rather than storing them.
This is a frequent and invisible cause of irreproducible results — the peptide hasn’t degraded, it’s on the tube wall.
6. Storing the stock and drawing from it repeatedly
The error: keeping one reconstituted vial and accessing it many times over weeks.
The mechanism: compounds several problems at once — repeated freeze–thaw, repeated air exposure, cumulative contamination risk, and stopper coring that sheds rubber particulates into the solution.
The fix: aliquot. It solves this error, error 2, and much of error 4 in a single step, and it’s the highest-value habit in the list.
7. pH extremes and inappropriate buffers
The error: dissolving into a buffer without considering the sequence.
The mechanism: deamidation of Asn and Gln accelerates markedly at neutral to basic pH, and is fastest for Asn-Gly motifs. Backbone hydrolysis accelerates at acidic pH, particularly at Asp-Pro bonds. Some sequences have a narrow pH range where they’re both soluble and stable.
The fix: dissolve in water first, then dilute into buffer. Where a sequence contains known-labile motifs, keep working pH slightly acidic (around 5–6) if the assay allows, since this is generally the most stable region for peptides.
8. Frost-free freezer storage
The error: storing long-term material in a standard frost-free unit.
The mechanism: frost-free freezers work by periodically warming to sublime accumulated ice. That means contents experience repeated temperature cycling — minor for a few weeks, meaningful over a year, and it also drives moisture migration inside vials.
The fix: use a manual-defrost freezer for anything archival. If only a frost-free unit is available, keep vials in a sealed container with desiccant to buffer the cycling.
9. Assuming appearance indicates integrity
The error: using material because it looks normal.
The mechanism: most chemical degradation is invisible. Oxidation, deamidation, and partial hydrolysis produce no visible change. Aggregation is sometimes visible and often not. A clear, colourless solution can be substantially degraded.
The fix: track dates and conditions rather than relying on inspection. Appearance rules material out — cloudiness, particulates, discolouration all mean discard — but it never rules it in.
10. Losing the link between vial and certificate
The error: discarding packaging, or not recording which lot went into which experiment.
The mechanism: a certificate of analysis describes a specific batch. Without the lot number, you have no documented basis for what your material’s purity or identity was — which matters when a result needs explaining, and matters more when it needs reproducing.
The fix: record the lot number in your notes at the point of use, alongside the reconstitution date and solvent. See what a certificate of analysis actually verifies for what that document establishes. Batch certificates are available for all our research compounds, including NAD+.
A short protocol that avoids most of this
- Let the vial reach room temperature, sealed
- Record the lot number and check it against the certificate
- Add solvent down the vial wall; swirl gently, don’t shake
- Confirm the solution is clear and free of particulates
- Aliquot immediately into single-use volumes
- Freeze aliquots at −20 °C or below, dark
- Thaw one aliquot per use; never refreeze
- Note reconstitution date and solvent
Steps 5 and 7 alone prevent the majority of preventable loss.
References
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 2010;27(4):544–575. doi:10.1007/s11095-009-0045-6
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharmaceutical Development and Technology, 2007;12(5):505–523. doi:10.1080/10837450701481157
- Reubsaet JL, Beijnen JH, Bult A, van Maanen RJ, Marchal JA, Underberg WJ. Analytical techniques used to study the degradation of proteins and peptides: chemical instability. Journal of Pharmaceutical and Biomedical Analysis, 1998;17(6–7):955–978. doi:10.1016/S0731-7085(98)00063-6
- Goebel-Stengel M, Stengel A, Taché Y, Reeve JR. The importance of using the optimal plasticware and glassware in studies involving peptides. Analytical Biochemistry, 2011;414(1):38–46. doi:10.1016/j.ab.2011.02.009
- Hawe A, Wiggenhorn M, van de Weert M, Garbe JH, Mahler HC, Jiskoot W. Forced degradation of therapeutic proteins. Journal of Pharmaceutical Sciences, 2012;101(3):895–913. doi:10.1002/jps.22812
Related reading
- Reconstituting and storing lyophilised peptides
- Cold chain and transit: what actually degrades material
- Lyophilisation: why research peptides ship as powder
- Bacteriostatic vs sterile water in laboratory preparation
All VANTA products are supplied for laboratory research use only. They are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.